22 23 24 25 Celiac disease (CeD) is an autoimmune disorder in which ingestion of dietary gluten 26 triggers an immune reaction in the small intestine 1,2 . The CeD lesion is characterized by 27 crypt hyperplasia, villous atrophy and chronic inflammation with accumulation of 28 leukocytes both in the lamina propria (LP) and in the epithelium 3 , which eventually 29 leads to destruction of the intestinal epithelium 1 and subsequent digestive complications 30 and higher risk of non-hodgkin lymphoma 4 . A lifetime gluten-free diet is currently the 31 only available treatment 5 . Gluten-specific LP CD4 T cells and cytotoxic intraepithelial 32 CD8+ T cells are thought to be central in disease pathology 1,6-8 , however, CeD is a 33 complex immune-mediated disorder and to date the findings are mostly based on 34 analysis of heterogeneous cell populations and on animal models. Here, we 35
To assess the changes in the immune cell landscape of the small intestine in CeD, we 45 isolated CD45 + immune cells from LP and the epithelial layer of duodenal biopsies obtained 46 from newly diagnosed CeD patients and from individuals with normal histology (controls) 47 ( Fig. 1a and Supplementary Table 1 ). In line with previous studies 11, 12 , analysis of the 48 markers used for index sorting shows that CeD harbors increased numbers of CD45+ cells in 49 LP and a higher fraction of CD3+ intraepithelial lymphocytes (IELs) as compared to controls 50
(Extended Data Fig. 1a, b) . A modified SORT-seq 10 single-cell RNA-seq protocol and 51 application of quality control cut offs yielded ~4,000 single cells with high quality RNA 52 profiles ( Fig. 1a and Extended Data Fig. 1c-e ). t-Distributed Stochastic Neighbor Embedding 53 (t-SNE) analysis revealed five major cell compartments that, based on typical lineage 54 markers (assessed by protein and/or mRNA), were annotated as T-cells (CD3), plasma cells 55 (PCs) (CD19 and SDC1 (CD138)), myeloid cells (CD14, CD11c and HLA-DR), mast cells 56 (MC) (KIT) and B cells (MS4A1 (CD20)) ( Fig. 1b-d) . Cell size and granularity are in line 57
with the classical phenotype of the cells (Fig. 1e ). The tSNE clusters were formed by 58 contribution from all donors with no considerable donor batch effect (Extended Data Fig. 1f ). 59 We applied the Wilcoxon rank sum test ('Seurat' pipeline 13 ) to identify cell type-60 specific transcripts distinguishing each cell population (Fig 1f and Supplementary Table 2 ). 61 We identified 181 genes differentially expressed in the T-cell compartment with IL7R, 62
GZMA, RORA amongst the top genes. For PCs, 104 genes largely consisting of 63 immunoglobulin related genes such as IGLC2, IGLC3, and IGHA1. We found 245 marker 64 genes distinguishing myeloid cells with SELENOP, SLC40A1, HLA-DRA and CD74 among 65 the top genes. MC analysis yielded 229 genes with the top ranked genes being HPGD, 66
LAPTM4A, VIM and LMO4. We could identify in total 98 genes as B cell markers with CR2, 67
RALGPS2 and FCRL2 as top ranked genes ( Fig. 1f ). CeD and control cells populate the same 68 major cell compartments but a different pattern within the MC, myeloid and T cell 69 compartments was observed. Virtually all CeD and control IELs clustered with the T-cell 70 compartment ( Fig. 1g ). 71 tSNE analysis of the MC compartment revealed 4 clusters (C0-C3). C1 is common to 72 controls and CeD, whereas C2 and C3 consist mostly of control and CeD cells, respectively 73 (Figs. 2a, b). MCs from each donor contributed to these three clusters except for C0, which is 74 donor-specific and was excluded from the subsequent analysis (Extended Data Fig. 2a ). 75
Cluster C3 cells, enriched in CeD, were smaller and less granular (Fig. 2c ). The three 76 clusters differ in their expression levels of C20orf194 and FKBP11 that are high in the 77 common cluster C1, whereas REG1A and HLA-DRB1 are high in the control cell cluster C3 78 and low in the CeD cluster C3 ( Fig. 2d and Supplementary Table 3 ). 79 tSNE analysis of the myeloid compartment revealed seven clusters (C0-C6) ( Fig. 2e ). 80
Clusters C0, C2, and C4 express higher levels of CD163 and lower levels of CD11c (Fig 2e,  81 g). C2 and C4 differentially express typical macrophage genes 14 ( Fig. 2h and Supplementary  82  Table 3 ) reminiscent of CD11c-mature macrophages (Mf) which are noticeably 83 underrepresented in CeD 15 ( Fig. 2f and Extended Data Fig. 2b, c) . Clusters C1 and C3 84 express higher levels of ITGAX (CD11c) and FCER1A reminiscent of immature Mf and of 85 dendritic cells (DC) 16 ( Fig. 2e, g) . CD11c-high cells were ordered from C1 to C3 and C6 cells 86 with C3 cells differentially expressing SLC38A1, PLAC8, SERPINB9, PPA1 and FCER1A 87 and C6 cells expressing CLEC10A, a marker associated with cDC2 17 (Fig. 2h ). Pseudotime 88 analysis revealed two trajectories originating from cluster C5 and diverging into a Mf and a 89 DC path that correspond to CD11c-low and CD11c-high cells, respectively ( Fig. 2i ). C6 cells 90 expressing CLEC10A are located between the two trajectories suggesting that this cluster 91 may originate from both the Mf and the DC pathway 16 . C5 cells differentially express 92
HELLPAR, FBXO22 and PRRG3 (Fig. 2h ). Note that the fluorescent antibody panel used in 93
the index sorting cannot distinguish C5 cells from the other myeloid cells (Extended Data 94 Fig. 2d , e). Using linear modeling and Bayesian statistics, we identified MYBL1 as a highly 95 expressed transcription factor (TF) in the shared origin of Mf and DC (C5) with ZEB1, IRF8 96
and YBX1 as the potential driver TFs of the MF path and MAF of the DC path ( Fig. 2i and 97
Supplementary Table 4 ). 98
Focusing on the humeral branch of the adaptive immune system, tSNE analysis 99 identified a small cluster of B cells (C2) and two prominent clusters (C0 and C1) of PCs ( Fig.  100 3a). FACS analysis showed that CD19+ PCs are significantly increased in CeD (Extended 101 Data Fig. 3a ). Based on transcriptome analysis, we noticed that B cells and PCs are rather 102 equally distributed across the clusters in CeD and control samples ( Fig. 3b and Extended 103
Data Fig. 3b , c). Beside subtle differences in immunoglobulin genes, no major difference 104 between the two PC clusters could be detected in mRNA, CD19 protein expression and cell 105 size and granularity (Extended Data Fig. 3d-f and Supplementary Table 5 ). Pseudotime 106 analysis revealed B cells at the beginning of the path and the two PCs clusters largely 107 intermingled along the trajectory (Fig. 3c ). Using our linear modeling approach, we identified 108 1597 and 1210 genes that are gradually up-or down-regulated (Supplementary Table 6 ). The 109
TFs ETS1, BCL11A, REL, and IRF8 are found to be highly expressed in B cells and their 110 expression is downregulated in PCs. MEIS2 and RUNX1 appear to be transiently upregulated 111 (bin 3) along the pseudotime path whereas XBP1, CREB3L2, SUB1and PRDM1 are among 112 the highest expressed TFs in fully differentiated PCs ( Fig. 3d and Supplementary Table 6 ). 113 tSNE analysis of the T-cell compartment ( Fig. 1b ) yielded three clusters of CD4 + T 114 cells (C0, C2 and C4) and four clusters of CD8 + T cells (C1, C3, C6 and C7) ( Fig. 4a and 115
Extended Data Fig. 4a ). Three clusters (C5, C8 and C9), that co-cluster with the T-cell 116 compartment when analyzing all CD45 + cells (Fig 1) , turn out to be distinct and are CD4 -117 /CD8 at mRNA levels and express no or very low levels of CD3 protein (Fig. 4a -c and 118
Extended Data Fig. 4c ). Expression of the canonical GNLY 18 amongst 29 other known and 119 novel genes, identified cluster C8 as natural killer (NK) cells ( Fig. 4e and Supplementary 120 Table 7 ). The NK cells are mainly present in the LP and more abundant in CeD than controls 121 ( Fig. 4 d, g ). Cells of cluster C9 were less present in CeD and identified as innate lymphoid 122 cells class 3 (ILC3) based on their expression of PCDH9, KIT, ALDOC, AHR and RUNX2 123 genes as previously reported 19 (Figs. 4a, d, e and Supplementary Table 7 ). 124
Strikingly, the CD4+ T cells in CeD are different from controls. While control cells 125 dominate cluster C0 expressing among other genes IL7R, ADAM19, TNFSF13, more than 126 85% of cells in C2 are from CeD (Fig. 4d ). C2 cells express genes including TBC1D4, MAF, 127 BIRC3, PHTF2, TFRC, TIGIT, IL32, FOXO1, GBP5, STAT1, and IL6R; several of these are 128 known to be expressed in both activated and regulatory T cells 20-22 ( Fig. 4e and 129 Supplementary Table 7) . Gene ontology analysis showed that these cells are significantly 130 enriched for signaling pathways including 'Cytokine Signaling in Immune system', 'NOD-131 like receptor signaling pathway' and 'Signaling by Interleukins' ( Supplementary Table 7 ). 132
Pseudotime analysis on C2 cells revealed 94 genes that are upregulated along the trajectory 133
with GFI1 and MED1 as the highest expressed TFs in the end of the path (Fig. 4f ). GFI1 and 134
MED1 have been shown to regulate T cell activation and NKT cell development, 135 respectively 23,24 . C4 cells are equally present in CeD and controls and express genes 136
including INPP4B, ANK3, FOXP1 and AHNAK (Figs. 4d, e ). 137
CD8 + T cells in CeD clusters are also very differently from controls. Clusters C1 and 138 C3 contain 75% and 95% CeD cells, respectively ( Fig. 4d) . Importantly, the clusters contain 139 the vast majority of both LP and intraepithelial CD8+ T cells ( Fig. 4h ). C1 cells differentially 140 express KLRC2 and KLRD1 both NK markers known to be involved in the cytotoxic activity 141 of CD8 IELs in CeD 25,26 . They also express TRGC2 suggesting that gamma delta T cells are 142 within this cluster. C3 cells express ITGAE and CD101, marker genes for resident memory T 143 cells 27 , and CCL5, HLA-DP and ENTPD1 (CD39), all expressed on activated CD8+ T cells 144 ( Fig. 4e and Supplementary Table 7 ). Interestingly, CD39 was recently shown to be a marker 145
for tumor-specific CD8 T cells 28 . Control CD8 + T cells mainly contribute to cluster C6 and 146
highly express LRP12 and GPR155. Cluster C7 contains slightly more CeD cells that 147 differentially express GZMK and KLRG1 suggesting they are recently recruited memory 148 CD8 + T cells 29 (Figs. 4a, d, e and Extended Data Fig. 4c and Supplementary Table 7 ). 149
Pseudotime analysis of clusters C1 and C3 revealed a developmental trajectory in which it 150 appears that C1 cells progress towards C3 cells. Applying our linear modeling, we found that 151
IKZF2 is the potential driving TF expressed in C1 cells and E2F3, RUNX2, and TCF3 among 152 others in C3 ( Fig. 4f and Supplementary Table 8 ). 153 Our analysis reveals that IELs in control individuals consist of two distinct populations: 154
CD3low and CD3high cells. The CD3high IELs are mostly CD8 + T cells (Figs. 4g). The 155
CD3low IELs are bigger in size and more granular as compared to the other cells in the T-cell 156 compartment (Extended Data Fig. 4b ) and are mainly CD4low/CD8low/ CD247 high (CD3 157 zeta) cells (cluster C5, Figs. 4a, b, g and Extended Data Fig. 4c ). We classify cluster C5 cells 158
as 'NK-T' as they express classical NK as well as T cell genes such as TRDC, GZMA, 159 FCER1G, CDH17, CD69, TYROBP and ID2 ( Fig. 4e and Supplementary Table 7 ). This 160 transcriptome profile is very similar to that described for natural IELs in mice 30 . The CD3low 161 cells in C5 are not exclusively intraepithelial as ~25% of the cells are located in the LP 162 (Extended Data Fig. 4d ). Moreover, C5 cells are remarkably underrepresented or absent in 163
CeD (Figs. 4d, h and Extended Data Fig. 4d ). Together, we find that the majority of CD8+ T 164 cells in both LP and epithelium express an activated phenotype in CeD compared to controls, 165
suggesting that CD8+ T cells in both compartments are actively involved in CeD pathology. 166
In conclusion, we find a dramatic change of the immune cell landscape in the active 167
CeD lesion. confirmed non-celiac controls have been enrolled in the study. See Table 1 for the list of  359 patients and their clinical information. Biopsies have been placed immediately in ice-cold 360 buffered saline, transported on ice, and processed within 4h. The study was approved by the 361
Norwegian Regional Committee for Medical Research ethics (REK 2012/341), and all 362 patients gave written informed consent. 363
Preparation of single cells suspension 364
To separate the epithelium and intraepithelial lymphocytes biopsies were shaken twice in 6. the original protocols. In brief, single immune cells were first indexed with canonical markers 399 of interest using the previously described antibodies and then sorted in 384-well PCR plates 400 (BioRad). The plates were already primed with unique primers per each well in which each 401 primer has a unique cell barcode with UMI incorporated to tag each RNA molecule in the 402 cell. Sorted plates then were kept frozen at -80 ˚C before proceeding to cDNA synthesis. The 403 frozen plates were shortly centrifuged at 1200 RPM for 1 minute at 4 ˚C and incubated in the 404 PCR machine at 60 ˚C for 2 minutes to break the cells and release the RNA. 405 We used micro-dispenser machine, Nanodrop II (BioNex) to dispend all the reagents in the 406 next steps of library preparation. After cell breakage, 100 nl lysis buffer contains RNase 407 inhibitor (RNasin PLUS promega), Triton X100, ERCC spike in control RNAs 1:50,000 408 diluted (Ambion) were added to each well, short spinned at 1200 RPM for 1 minute and 409 incubated in the PCR machine at 65 ˚C for 2 minutes and then immediately put on ice for 5 410 minutes. 411
Then first 150 nl cDNA reaction mix contains first strand cDNA synthesis buffer 412 (Invitrogen), SuperscriptII reverse transcriptase (Invitrogen), 0.1M DTT and RNasein PLUS 413
(promega) was added to each well of the plate and the plates were spinned at 1200 RPM at 4 414 ˚C for 1 minute and placed in PCR machine at 42 ˚C for 1 hour followed by 10 minutes 415 enzyme deactivation at 70 ˚C and immediately placed on ice. 416
Then, the 500 nl second strand DNA reaction mix contains second strand cDNA synthesis 417 buffer (Invitrogen), 10 mM dNTP, E.Coli DNA ligase enzyme (NEB), E.coli DNA 418 polymerase enzyme (NEB) and RNaseH enzyme (com) was added to each well of the plate 419 and then plates were spinned for 1 minute at 1200 RPM and placed in the PCR machines at 420 16 ˚C for 2 hours followed by enzyme deactivation at 70 ˚C for 10 minutes and then placed 421 on ice. 422
To remove the excess remainder of the primers in the reaction mix in each well, we used 423 exonuclease-I enzyme (NEB) and incubated the plates at 37 ˚C for 20 minutes followed by 424 enzyme deactivation at 85 ˚C for 15 minutes and immediately placed the plates on ice. 425
To reduce the DNA loss during the subsequent steps of library preparation, we linearly 426 amplified the cDNA content of each well using unidirectional linear-PCR using Pfu DNA 427 polymerase enzyme (Promega), forward primer against the common sequence of the T7-P5 428 part of the original oligo-dT primers and ran the linear-PCR for 15 cycles with 2 minutes 429 preheating at 95˚C, then sequential cycles of 30 seconds at 94˚C, 30 seconds at 50˚C and 3 430 minutes at 72˚C and ended by incubation at 72˚C for 5 minutes and then placed plates on ice. 431
After linear amplification of the DNA content in each well, the reaction solution of all wells 432 per each plate were pooled together (~ 600 ul) and the DNA was cleaned up using AMPure 433 XP beads by mixing 100 ul XP beads with 600 ul clean up buffer contains PEG and tween 434 and adding it to the DNA pool. The DNA-bond beads then washed two times with 80% 435 ethanol and the DNA was eluted in 22 ul EB buffer. 436
Then the amplified single strand DNA fragments of each pool was second stranded using 437 second strand DNA synthesis buffer (NEB), first strand cDNA synthesis buffer(NEB), 0.1M 438 DTT, random hexamer primer mix (Thermo), dNTP mix, E.coli DNA polymerase (NEB) and 439 E.coli DNA ligase (NEB) in 50 ul reaction volume and incubated for 2 hours at 16˚C. Then
